CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Omeicos Therapeutics GmbH

For profitWebsite ↗

Also known as: Managing Director | Omeicos Therapeutics GmbH

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

May 22, 2023

Timeline

2010s

Jun 1, 2013
Omeicos Therapeutics GmbH— Founded

Drugs by trial phase (2 distinct, 4 trials)

Phase 4 (1 own, 0 via acquisition)

cariprazine

Phase 2 (1 own, 0 via acquisition)

omt-28

Indications

Studied for

Atrial Fibrillation

Recent trials (6)

NCT05972954Lead sponsorPhase 2May 22, 2023
NCT05972954Study directorPhase 2May 22, 2023
NCT05384483Overall official - principal investigatorPhase 4Jul 15, 2022
NCT03906799Lead sponsorPhase 2Mar 19, 2019
NCT03906799Study directorPhase 2Mar 19, 2019
NCT03078738Lead sponsorPhase 1Feb 8, 2017

Details

Founded: Berlin, DE Jun 1, 2013
Last known activity: May 22, 2023